BOLT BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7375 USD | +0.34% |
|
-0.38% | -34.15% |
| May. 20 | Bolt Biotherapeutics, Inc. Announces Management Changes | CI |
| May. 20 | Bolt Biotherapeutics, Inc. Announces Chief Executive Officer Changes | CI |
Chart calendar Bolt Biotherapeutics, Inc.
c598b39ad9ec11b353c84efc4258de6.PjUBGZn1vAXLa4Q2TYyobIl7hOaTYb3YHmwNUXLLnxI.B1tQU6q7hGmvCs19EsDHLuAt6LmkUtKTdyRjACGZ3iVJRl5717bzVbpdyQ~47bf30d1682e50f58851c9062ad2a61d
Upcoming events on Bolt Biotherapeutics, Inc.
Past events on Bolt Biotherapeutics, Inc.
| 2024-06-12 02:00 pm | Annual General Meeting |
| 2024-05-14 04:30 pm | Strategic Update Call |
| 2024-05-14 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-21 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-05 02:50 pm | TD Cowen Health Care Conference |
| 2023-12-06 01:00 pm | San Antonio Breast Cancer Symposium - Poster No: PO1-20-06 |
| 2023-11-14 08:35 am | Stifel Healthcare Conference |
| 2023-11-09 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 720 |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 716 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1147-D |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 821 |
| 2023-10-23 10:30 am | European Society for Medical Oncology Congress |
| 2023-09-12 | H.C. Wainwright Global Investment Conference |
| 2023-09-12 03:35 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-07 04:10 pm | Q2 2023 Earnings Release |
| 2023-08-07 10:00 am | BTIG Virtual Biotechnology Conference |
| 2023-06-12 02:00 pm | Annual General Meeting |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 2538 |
| 2023-05-11 04:05 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,22 | 0,23 0,26 -10.38% | 1,26 2,20 -42.75% | 5,73 4,82 18.94% | 7,88 7,68 2.62% | 8,93 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -47,2 -42,5 -10.92% | -83,1 -82,2 -1.13% | -79,1 -91,0 13.08% | -65,1 -70,8 8.01% | -94,6 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -49,2 -44,5 -10.52% | -92,8 -88,7 -4.6% | -90,3 -93,0 2.92% | -76,2 -75,4 -1.11% | -65,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -60,7 -42,5 -43.05% | -98,6 -97,1 -1.55% | -88,1 -90,3 2.42% | -69,2 -69,6 0.52% | -54,9 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -60,7 -42,5 -42.74% | -98,6 -96,4 -2.32% | -88,1 -90,4 2.5% | -69,2 -68,6 -0.92% | -51,1 |
|
EPS USD | Released Forecast Spread | -2,18 | 0,00 0,00 - | -2,97 -2,96 -0.23% | -2,36 -2,42 2.28% | -1,83 -1,85 0.81% | -1,34 |
| Announcement Date | 10/08/20 | 31/03/21 | 30/03/22 | 29/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,81 0,50 62.6% | 1,39 0,50 178.6% | 2,11 1,23 71.6% | 1,41 1,54 -8.18% | 1,83 1,73 5.86% | 1,43 1,80 -20.42% | 2,53 1,76 43.84% | 2,09 1,79 16.64% | 5,27 2,25 134.3% | 0,89 | 1,42 | 1,33 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -23,9 -27,8 14.05% | -23,1 -26,9 14.25% | -22,3 -21,3 -4.89% | -21,0 -22,7 7.21% | -18,4 -21,5 14.2% | -19,8 -20,0 0.9% | -18,2 -20,3 10.45% | -19,8 -20,1 1.67% | -17,1 -20,4 16.26% | -21,0 | -14,8 | -12,7 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,7 -27,7 14.44% | -22,7 -26,8 15.36% | -21,8 -21,0 -3.61% | -20,0 -22,2 9.84% | -17,0 -20,4 16.85% | -18,1 -18,6 2.91% | -16,3 -18,6 12.62% | -17,9 -18,3 1.95% | -10,8 -18,7 42.19% | -19,4 | -13,3 | -11,4 | ||
|
Net income Million USD | Released Forecast Spread | -23,7 -27,1 12.63% | -22,7 -25,7 11.65% | -21,8 -21,5 -1.2% | -20,0 -21,9 8.73% | -17,0 -18,9 9.99% | -18,1 -19,9 9.48% | -16,3 -17,4 6.72% | -17,9 -17,5 -2.48% | -10,8 -18,7 42.19% | -18,2 | -11,7 | -10,3 | ||
|
EPS USD | Released Forecast Spread | -0,64 -0,72 11.52% | -0,61 -0,69 11.17% | -0,58 -0,57 -1.31% | -0,53 -0,58 9.01% | -0,45 -0,50 10% | -0,48 -0,47 -1.59% | -0,43 -0,46 6.52% | -0,47 -0,48 1.05% | -0,28 -0,49 43.24% | -0,48 | -0,31 | -0,27 | -0,18 | -0,18 |
| Announcement Date | 12/05/22 | 10/08/22 | 10/11/22 | 29/03/23 | 11/05/23 | 07/08/23 | 09/11/23 | 21/03/24 | 14/05/24 | - | - | - | - | - |
More events
Past sector events for Bolt Biotherapeutics, Inc.
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BOLT Stock
- Calendar Bolt Biotherapeutics, Inc.
